Public biotechnology supplier
Appears in 1 story · Last updated Nov 11, 2026
Removed from the S&P SmallCap 600 on October 8; acquisition by Repligen pending
Freshworks joined the S&P SmallCap 600 on October 8, taking the seat BioLife Solutions gave up as Repligen buys it for about $1.5 billion. The stock hit a 52-week high of $13.99 on October 6 as index funds bought ahead of the switch.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
